<DOC>
	<DOCNO>NCT00004429</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess clinical safety long term effect recombinant human growth hormone define range nutritional index malnourish chronic hemodialysis continuous ambulatory peritoneal dialysis patient .</brief_summary>
	<brief_title>Randomized Study Recombinant Human Growth Hormone Patients Chronic Hemodialysis Peritoneal Dialysis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo-controlled , cross-over study . Prior randomization patient 's protein calorie intake assess optimize possible . Patients randomize receive either placebo recombinant human growth hormone subcutaneously every day 6 month . At end 6 month period , patient undergo 4 week washout period . After washout period , patient crossed-over alternate regimen additional 6 month follow another 4 week washout period .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics On hemodialysis peritoneal dialysis 3 month Optimally dialyze ( urea reduction ratio great 65 % ) Suboptimal nutritional status identify one follow criterion : Protein catabolic rate le 0.85 g/kg/d calculate three point urea kinetic modeling least 2 occasion past 6 month Progressive unintentional weight loss 2.5 % initial ideal body weight and/or patient weighs le 90 % ideal body weight Biochemical parameter malnutrition define two follow measurement past 3 month : Serum albumin great 3.7 g/dL Serum transferrin concentration le 250 mg/dL Serum prealbumin concentration le 30 mg/dL Serum IGF1 concentration le 0.250 mg/mL Patient Characteristics No active autoimmune , inflammatory , infectious disease At least 6 month since document malignancy No unusual dietary restriction At least 3 month since peritonitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>end stage renal disease</keyword>
	<keyword>rare disease</keyword>
	<keyword>renal genitourinary disorder</keyword>
</DOC>